Chemoprevention of prostate cancer

被引：0

作者：

Eschwege, P

机构：

来源：

PROGRES EN UROLOGIE | 2003年 / 13卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1262 / 1267

页数：6

相关论文

共 57 条

[1] Use of animal models in defining efficacy of chemoprevention agents against prostate cancer
Bosland, MC
[J]. EUROPEAN UROLOGY, 1999, 35 (5-6) : 459 - 463
[2] Bosland MC, 2002, EUR J CANCER PREV, V11, pS18
[3] Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein
Bosland, MC
Kato, I
Melamed, J
Taneja, S
Lepor, H
Torre, P
Walden, P
Zeleniuch-Jacquotte, A
Lumey, LH
[J]. UROLOGY, 2001, 57 (4A) : 202 - 204
[4] The epidemiology of prostate cancer
Boyle, P
Severi, G
Giles, GG
[J]. UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (02) : 209 - +
[5] CHEMOPREVENTION OF PROSTATE-CANCER
BRAWLEY, OW
THOMPSON, IM
[J]. UROLOGY, 1994, 43 (05) : 594 - 599
[6] Carbone PP, 1998, CANCER EPIDEM BIOMAR, V7, P907
[7] Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia
Clark, LC
Marshall, JR
[J]. UROLOGY, 2001, 57 (4A) : 185 - 187
[8] Constantinou AI, 1996, ANTICANCER RES, V16, P3293
[9] Conti CJ, 1996, IARC SCI PUBL, P249
[10] A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues
Costello, AJ
[J]. UROLOGY, 2001, 57 (4A) : 182 - 184

← 1 2 3 4 5 6 →